Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Payables (2016 - 2025)

HealthLynked (HLYK) has disclosed Payables for 10 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables rose 19.45% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 19.45% increase, with the full-year FY2024 number at $892407.0, down 25.54% from a year prior.
  • Payables was $1.1 million for Q3 2025 at HealthLynked, down from $1.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.1 million in Q1 2023 to a low of $760390.0 in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2024 define the central range for Payables.
  • Peak YoY movement for Payables: surged 174.77% in 2023, then crashed 53.64% in 2024.
  • HealthLynked's Payables stood at $1.1 million in 2021, then skyrocketed by 73.55% to $1.9 million in 2022, then plummeted by 36.73% to $1.2 million in 2023, then fell by 25.54% to $892407.0 in 2024, then rose by 21.01% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Payables are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.3 million (Q1 2025).